HS-20093
Showing 51 - 75 of 549
Hidradenitis Suppurativa Trial in Worldwide (Bimekizumab, Placebo)
Active, not recruiting
- Hidradenitis Suppurativa
- Bimekizumab
- Placebo
-
Birmingham, Alabama
- +87 more
Feb 2, 2023
Advanced or Metastatic NSCLC Trial in Guangzhou (HS-10375)
Recruiting
- Advanced or Metastatic NSCLC
-
Guangzhou, Guangdong, ChinaSun Yat-sen University Cancer Center
Jun 27, 2022
Nontuberculous Mycobacterial Lung Disease, Nontuberculous Mycobacterium Infection Trial in New York, Portland, Toronto
Recruiting
- Nontuberculous Mycobacterial Lung Disease
- Nontuberculous Mycobacterium Infection
- Hypertonic saline
- +3 more
-
New York, New York
- +2 more
Jan 27, 2023
Hidradenitis Suppurativa Trial (Eltrekibart, Placebo)
Not yet recruiting
- Hidradenitis Suppurativa
- Eltrekibart
- Placebo
- (no location specified)
Sep 14, 2023
Advanced Non-Small-Cell Lung Cancer Trial in Tianjin (HS-10376)
Recruiting
- Advanced Non-Small-Cell Lung Cancer
-
Tianjin, Tianjin, ChinaTianjin Medical University Cancer Institute and Hospital
Jun 27, 2022
Colorectal Polyp Trial (Cold snare endoscopic mucosal resection, Hot snare endoscopic mucosal resection)
Recruiting
- Colorectal Polyp
- Cold snare endoscopic mucosal resection
- Hot snare endoscopic mucosal resection
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
Oct 15, 2022
Hidradenitis Suppurativa, Quality of Life Trial in Bronx
Completed
- Hidradenitis Suppurativa
- Quality of Life
-
Bronx, New YorkMontefiore Medical Center
Jan 18, 2023
Hidradenitis Suppurativa Mail Survey
Active, not recruiting
- Hidradenitis Suppurativa
-
Winston-Salem, North CarolinaWake Forest Baptist Medical Center
Jun 28, 2022
Breast Cancer Trial in Shanghai (HS-10352 combined with fulvestrant (Stage 1), HS-10352 combined with fulvestrant (Stage 2))
Recruiting
- Breast Cancer
- HS-10352 combined with fulvestrant (Stage 1)
- HS-10352 combined with fulvestrant (Stage 2)
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Aug 15, 2022
MDD (MDD) Trial (HS-10353 30mg oral capsules, HS-10353 50mg oral capsules, Placebo for HS-10353 30mg capsules)
Not yet recruiting
- Major Depressive Disorder (MDD)
- HS-10353 30mg oral capsules
- +3 more
- (no location specified)
Jul 10, 2023
Advanced Solid Tumor Trial in Wuhan (HS-10370)
Not yet recruiting
- Advanced Solid Tumor
-
Wuhan, Hubei, ChinaUnion Hospital Tong Ji Medical College, HuaZhong University of S
May 5, 2022
Advanced Solid Tumor Trial in Xi'an (HS-10381)
Recruiting
- Advanced Solid Tumor
-
Xi'an, Sichuan, ChinaWest China Hospital of Sichuan University
Jul 4, 2022
Hidradenitis Suppurativa Trial in Worldwide (Bimekizumab, Placebo)
Completed
- Hidradenitis Suppurativa
- Bimekizumab
- Placebo
-
Fountain Valley, California
- +90 more
Nov 8, 2022
Nonsmall Cell Lung Cancer Trial in Anaheim, Beverly Hills, Aurora (HS-10296)
Active, not recruiting
- Nonsmall Cell Lung Cancer
-
Anaheim, California
- +9 more
Dec 27, 2022
Collect inReal-world populatIon Data on Treatment Pattern of
Not yet recruiting
- Hidradenitis Suppurativa
- secukinumab
- (no location specified)
Jun 26, 2023
Periodontal Disease and Diabetes Mellitus
Completed
- Periodontitis, Adult
- GCF levels of fetuin A and hsCRP evaluation
-
Fayoum, Egyptfaculty of dentistry, Fayoum university
Sep 26, 2023
Behavior, Eating Trial (High-Fat/High-Sugar (HF/HS) Diet, Low-Fat/Low-Sugar (LF/LS) Diet)
Completed
- Behavior, Eating
- High-Fat/High-Sugar (HF/HS) Diet
- Low-Fat/Low-Sugar (LF/LS) Diet
- (no location specified)
Oct 7, 2022
Hidradenitis Suppurativa, Hyperhidrosis Trial in Pittsburgh (Botulinum toxin)
Recruiting
- Hidradenitis Suppurativa
- Hyperhidrosis
- Botulinum toxin
-
Pittsburgh, PennsylvaniaUniversity of Pittsburgh Medical Center = Presbyterian Shadyside
Jul 5, 2022
Hidradenitis Suppurativa (HS) Trial (blood sampling)
Not yet recruiting
- Hidradenitis Suppurativa (HS)
- blood sampling
- (no location specified)
Feb 9, 2023
Hidradenitis Suppurativa Trial in United States (INCB054707)
Completed
- Hidradenitis Suppurativa
-
Los Angeles, California
- +3 more
Sep 14, 2022
Essential Hypertension Trial (NW Roselle, Captopril 25Mg Tab)
Not yet recruiting
- Essential Hypertension
- NW Roselle
- Captopril 25Mg Tab
- (no location specified)
Nov 15, 2023
Hidradenitis Suppurativa (HS) Trial in Worldwide (Povorcitinib, Placebo)
Recruiting
- Hidradenitis Suppurativa (HS)
- Povorcitinib
- Placebo
-
Phoenix, Arizona
- +44 more
Jan 12, 2023